Hosted on MSN6d
FDA approves Johnson & Johnson’s Tremfya to treat Crohn’s disease
In January, 2025, J&J’s nasal spray Spravato secured a label expansion from the FDA for use as a single agent in adults with ...
WSAV Savannah on MSN2mon
Nose spray to treat depression? FDA approves first-of-its-kind medicine
NEW YORK (WPIX) – The U.S ... The nasal spray can be given to people who haven’t seen improvements in their depression after taking at least two oral medications, according to Johnson ...
pharmaphorum2y
FDA approves Janssen’s ketamine-based nasal antidepressant
The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...
Business Insider6y
Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential
Called Spravato, a brand name for esketamine, and developed by Johnson & Johnson, the drug is a nasal spray designed ... Administration (FDA) approved Johnson & Johnson's new drug, which is ...